Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and Translational Medicine 2024-08, Vol.14 (8), p.e1792-n/a
Hauptverfasser:	Li, Haoran, Liu, Zheng, Chen, Shaoyi, Cai, Jingsheng, Wang, Peiyu, Chen, Kezhong, Qiu, Mantang
Format:	Artikel
Sprache:	eng
Schlagworte:	Acrylamides - pharmacology Acrylamides - therapeutic use Aniline Compounds - pharmacology Aniline Compounds - therapeutic use Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Apoptosis Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics Cell Line, Tumor Chromosomes Humans Indoles Kinases Letter to the Journal Lung cancer Lung cancer, Non-small cell Lung Neoplasms - drug therapy Lung Neoplasms - genetics Phosphatase Phosphatases Protein expression Proteins PTEN Phosphohydrolase - genetics PTEN Phosphohydrolase - metabolism Pyrimidines RNA RNA, Circular - genetics Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!